By Mill Chart
Last update: May 6, 2024
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Ticker | Change | Comment |
---|---|---|
GLYC | -77.6% | Despite yesterday's decline, GLYCOMIMETICS INC (NASDAQ:GLYC) experienced a further 77.6% decrease in share price during Monday's pre-market session, reaching $0.41. A press release (GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)) was released earlier today. |
AFIB | -36.49% | ACUTUS MEDICAL INC's (NASDAQ:AFIB) stock price decreased by 36.49% to $0.09. Shareholders saw the stock price going 76.28% lower is the past 6 months. |
MMAT | -29.5% | Despite yesterday's decline, META MATERIALS INC (NASDAQ:MMAT) experienced a further 29.5% decrease in share price during Monday's pre-market session, reaching $2.36. The stock is trading 68.49% lower than 6 months ago. |
EYPT | -29.08% | Today's pre-market session reveals a 29.08% decline in the stock price of EYEPOINT PHARMACEUTICALS INC (NASDAQ:EYPT), now priced at $14.0. In the last 3 months the share price dropped with 31.22%. |
SGBX | -28.16% | SAFE & GREEN HOLDINGS CORP's (NASDAQ:SGBX) shares fell 28.16% to $3.98 during Monday's pre-market session. Following yesterday's gain of 89.08%, NASDAQ:SGBX experiences a 28.16% decrease in today's pre-market session, indicating a pullback from the previous session's performance. Earlier today the company had a press release: Safe & Green Holdings Corp Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules. |
LPTV | -17.44% | During Monday's pre-market session, the shares of LOOP MEDIA INC (NYSEARCA:LPTV) declined by 17.44%, reaching $0.26. In the last 3 months the stock lost 52.75%. |
MPW | -14.58% | The stock price of MEDICAL PROPERTIES TRUST INC (NYSE:MPW) is declining by 14.58%, reaching $4.16 during Monday's pre-market session. Shareholders saw the stock price going 20.25% higher in the past month. |
OCUL | -13.29% | OCULAR THERAPEUTIX INC's (NASDAQ:OCUL) stock price recorded a 13.29% decrease, falling to $5.35. NASDAQ:OCUL is releasing earnings today. Shareholders saw the stock price going 26.9% lower in the past month. |
VAXX | -13.18% | Monday's pre-market session showed a 13.18% decrease in the stock price of VAXXINITY INC-A (NASDAQ:VAXX), reaching $0.12. Yesterday's significant 35.41% gain in NASDAQ:VAXX is met with a 13.18% decline in today's pre-market session, reflecting a shift in market sentiment. VAXXINITY INC-A is releasing earnings today. |
POAI | -12.71% | Despite yesterday's decline, PREDICTIVE ONCOLOGY INC (NASDAQ:POAI) experienced a further 12.71% decrease in share price during Monday's pre-market session, reaching $1.58. In the last 3 months the stock lost 41.23%. |
For the full premarket loser list go to our premarket losers page.
MEDICAL PROPERTIES TRUST INC
NYSE:MPW (5/17/2024, 7:14:20 PM)
After market: 5.06 +0.05 (+1%)5.01
-0.11 (-2.15%)
Could this make Medical Properties Trust a lower-risk stock?
Sky-high dividend yields suggest these stocks are too hot to handle, but billionaires bought millions of shares in the first quarter.
This company's fortunes just darkened significantly.
This company's fortunes just darkened significantly.
There is a lot of evidence that suggests it is not very safe at all.
Medical Properties Trust Inc (NYSE:MPW) experienced a remarkable surge of close to 17% on Monday, catching the attention of investors and analysts alike. This surge can be primarily attributed to short covering, as MPW is one of the most shorted stocks on the NYSE, with approximately 38% of its float being short. The rally on […]
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Medical Properties Trust's unhealthy portfolio has cast a shadow on its healthier properties.
MPW earnings call for the period ending March 31, 2024.
MPW stock results show that Medical Properties Trust missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.